Mindpeak Announces Global Reseller Agreement with Leica Biosystems

March 19, 2026

We are excited to announce a global reseller agreement with Leica Biosystems, a Danaher company and global leader in digital pathology. This partnership marks an important step in expanding access to Mindpeak’s AI-powered pathology solutions worldwide.

By integrating our AI applications into the Aperio HALO AP platform and Aperio AI Store, laboratories and biopharma teams can seamlessly bring advanced biomarker and tissue analysis into their daily workflows -supporting greater efficiency, reproducibility, and scalability.

Together, we aim to accelerate biomarker discovery and enable smarter decisions across the drug development lifecycle.

Read the full Press Release here: https://www.einpresswire.com/article/900262524/mindpeak-announces-global-reseller-agreement-with-leica-biosystems-to-expand-access-to-ai-pathology-solutions

Press Release

Related reading

Press Release

8 min read

ZEISS and Mindpeak partner to advance Multiplex Immunofluorescence (mIF) solutions for pathology

The future of pathology is here!

‍ZEISS Microscopy and Mindpeak GmbH partner to develop an integrated Multiplex Immunofluorescence (mIF) solution, combining ZEISS’s advanced instruments with Mindpeak’s AI-powered pathology analysis.

Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF. The joint solution will integrate both companies' existing offerings to enhance the value for the users and address multiple market segments.The partnership combines complementary competencies and expands both companies’ reach in the growing mIF market.

…making excellence a habit! Mindpeak achieves ISO13485:2016 certification for its QMS

Today, we’re excited to share a major milestone: Mindpeak GmbH has officially achieved ISO 13485:2016 certification from the British Standards Institution (BSI)!

This globally recognized certification confirms that our Quality Management System meets the highest international standards for safety, reliability, and compliance in the medical device industry. It reflects our dedication to delivering innovative solutions that healthcare providers can trust.

At Mindpeak, quality is at the heart of everything we do. From product design to delivery, this certification underscores our commitment to ensuring that our products meet the most rigorous regulatory requirements while improving outcomes for patients and healthcare professionals alike.

This accomplishment wouldn’t have been possible without the dedication and expertise of our team. Here’s to continuing to raise the bar in quality, safety, and innovation!

Mindpeak and Sagis Diagnostics to launch Collaborative Study on AI-Enhanced Detection of Nail Mycosis

Mindpeak announces its collaboration with Sagis Dx to conduct a spearheading study, assessing the efficacy of the new Mindpeak Onychomycosis AI algorithm.

The Mindpeak Onychomycosis AI algorithm is designed to automate the process of detecting hyphae from multiple slides, by efficiently identifying target structures that may appear sparsely in whole-slide images. The algorithm aims to reduce the risk of missed diagnoses.

Read full article:https://lnkd.in/eHrpcezW

Ready to advance your diagnostics

Connect with our team to explore how precision pathology works in your setting

Request consult